Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NS-0200 in Individuals With Hypertension
NCT07647003Phase 2Not yet recruiting
- Sponsor
- NuSirt Biopharma
- Start
- Oct 2026
- Primary completion
- May 2027
01
Overview
A Phase 2 trial of leucine + metformin + sildenafil in hypertension (HTN), sponsored by NuSirt Biopharma. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
leucine + metformin + sildenafil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07647003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07647003.